Salt Lake City, UT, United States of America

Eric W Schmidt

This inventor holds 13 USPTO granted patents and 7 published patent applications and 2 EPO patents, primarily in Peptide Synthesis. Top assignees: University of Utah Research Foundation, Tufts University, Virginia Tech Intellectual Properties Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eric W Schmidt. Retrieved from https://idiyas.com/inventor/eric-w-schmidt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 13 

% Patents Active = 84.6

 

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Wichita, KS (US) (2010 - 2014)
  • Salt Lake City, UT (US) (2013 - 2021)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibacterial
Cyclopeptides
Apicomplexan Infections
Ribosomally Synthesized Peptides
Antifungal Compounds
Neuroactive Compounds
Cyclic Peptide Synthesis
Acoustical Device
Wind Turbine
Soundhole Device
13 patents (USPTO):Explore Patents

Title: Innovations of Eric W. Schmidt: Pioneering Patents in Antibacterial and Apicomplexan Research

Introduction: Eric W. Schmidt, based in Salt Lake City, Utah, is a distinguished inventor with a commendable portfolio, holding 13 patents. His innovative contributions largely focus on combating bacterial infections and diseases caused by Apicomplexan pathogens.

Latest Patents: Among his latest patents is one for "Antibacterial cyclopeptides targeting acinetobacter and other gram-negative pathogens." This invention encompasses cyclopeptides and elaborates on methods utilizing these compounds to address bacterial infections linked to Gram-negative pathogens. The abstract serves as a scanning tool for researchers in the field, outlining essential methods without being limiting. Another notable patent is "Methods and compositions for prevention and treatment of Apicomplexan infections." This patent provides methods for preventing and treating diseases caused by apicomplexan infections, employing compounds such as tartrolon D and E, including their isomers.

Career Highlights: Eric W. Schmidt's career includes pivotal roles at the University of Utah Research Foundation, where he contributed significantly to research and development in biotechnology and pharmaceuticals. His efforts have greatly advanced our understanding of treatment options for bacterial and parasitic infections.

Collaborations: Throughout his career, Schmidt has collaborated with prominent scientists such as Joseph O. Falkinham and Peter W. Jeffs. These partnerships have aided in the development of groundbreaking solutions to pressing health issues.

Conclusion: Eric W. Schmidt’s work exemplifies innovation in the fields of microbiology and pharmaceutical sciences. With a series of impactful patents and collaborations, he continues to lead the charge in addressing the challenges posed by bacterial and parasitic infections. His contributions not only advance scientific understanding but also pave the way for effective treatments in the healthcare sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…